Arthrizyme is a proprietary blend of systemic enzymes designed to rapidly reduce inflammation associated with arthritis pain. Arthrizyme, however, is not limited to its anti-inflammatory effect, but also assists the body in the healing process by breaking down fibrin in joints and muscles.
Dr. Anthony Martin, Director of Research at Martin Nutraceuticals Inc. suggests that these results open the door for clinically proven Arthrizyme. “As we prepare to launch Arthrizyme across North American, people will have an alternative to glucosamine and chondroitin. The timing couldn’t be better for us as this study proves the window of opportunity is there to tackle a major health problem with Arthrizyme.”
Arthrizyme is fast acting, usually improving symptoms within the first few days.